ANDREW TECHNOLOGIES LLC

Profile

Company Names

ANDREW TECHNOLOGIES LLC

Addresses

1421 EDINGER AVENUE, SUITE D, TUSTIN, CA 92780

3 SOUTH HADDON AVENUE, 2ND FLOOR, SUITE 3, HADDONFIELD, NJ 08033

3 SOUTH HADDON AVENUE, SUITE 3, HADDONFIELD, NJ 08033

Phone Numbers

949-922-5028
770-886-6585

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

BIOTECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$21,783,192.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-12-31 
$738,350.00 
$3,000,000.00 
$2,261,650.00 
Debt 
3
2015-12-03 
$7,783,389.00 
$32,660,237.00 
$24,876,848.00 
Equity 
2
2013-05-17 
$6,261,769.00 
$9,761,769.00 
$3,500,000.00 
Equity 
1
2011-03-11 
$6,999,684.00 
$6,999,684.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
 
ALBRIGHT 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
A. 
ALBRIGHT 
EXECUTIVE OFFICER, DIRECTOR
MARK 
 
ANDREW 
EXECUTIVE OFFICER, DIRECTOR
MARK 
S. 
ANDREW, M.D. 
EXECUTIVE OFFICER, DIRECTOR
RONALD 
 
CASTILLO 
EXECUTIVE OFFICER
HERBERT 
 
CRANE 
EXECUTIVE OFFICER
LUIS 
 
DAVILA 
EXECUTIVE OFFICER
DAVID 
 
DE LEEUW 
DIRECTOR
WILLIAM 
 
DOYLE 
DIRECTOR
STEPHANE 
 
GOBRON 
EXECUTIVE OFFICER
TIMOTHY 
 
LANGLOSS 
EXECUTIVE OFFICER, DIRECTOR
MYLINA 
 
LINCOLN-ANDREW 
DIRECTOR
GERT 
LENNART 
PERLHAGEN 
DIRECTOR
LENNART 
 
PERLHAGEN 
DIRECTOR
SIDHARTA 
 
PRAKASH 
DIRECTOR
SIDDHARTH 
 
PRAKASH, M.D. 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-17 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-03-11 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
WALTER GREENBLATT + ASSOCIATES, LLC
WALTER GREENBLATT + ASSOCIATES, LLC